These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26573343)

  • 1. Thioridazine in PLGA nanoparticles reduces toxicity and improves rifampicin therapy against mycobacterial infection in zebrafish.
    Vibe CB; Fenaroli F; Pires D; Wilson SR; Bogoeva V; Kalluru R; Speth M; Anes E; Griffiths G; Hildahl J
    Nanotoxicology; 2016 Aug; 10(6):680-8. PubMed ID: 26573343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against
    Hakkimane SS; Shenoy VP; Gaonkar SL; Bairy I; Guru BR
    Int J Nanomedicine; 2018; 13():4303-4318. PubMed ID: 30087562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles as drug delivery system against tuberculosis in zebrafish embryos: direct visualization and treatment.
    Fenaroli F; Westmoreland D; Benjaminsen J; Kolstad T; Skjeldal FM; Meijer AH; van der Vaart M; Ulanova L; Roos N; Nyström B; Hildahl J; Griffiths G
    ACS Nano; 2014 Jul; 8(7):7014-26. PubMed ID: 24945994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
    Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
    J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Francisella infections via PLGA- and lipid-based nanoparticle delivery of antibiotics in a zebrafish model.
    Ulanova LS; Pinheiro M; Vibe C; Nunes C; Misaghian D; Wilson S; Zhu K; Fenaroli F; Winther-Larsen HC; Reis S; Griffiths G
    Dis Aquat Organ; 2017 Jun; 125(1):19-29. PubMed ID: 28627489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles.
    Dutt M; Khuller GK
    J Antimicrob Chemother; 2001 Jun; 47(6):829-35. PubMed ID: 11389115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapeutic efficacy of thioridazine as an adjunct drug in a murine model of latent tuberculosis.
    Singh A; Sharma S
    Tuberculosis (Edinb); 2014 Dec; 94(6):695-700. PubMed ID: 25305001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(lactide-co-glycolide)-rifampicin nanoparticles efficiently clear Mycobacterium bovis BCG infection in macrophages and remain membrane-bound in phago-lysosomes.
    Kalluru R; Fenaroli F; Westmoreland D; Ulanova L; Maleki A; Roos N; Paulsen Madsen M; Koster G; Egge-Jacobsen W; Wilson S; Roberg-Larsen H; Khuller GK; Singh A; Nyström B; Griffiths G
    J Cell Sci; 2013 Jul; 126(Pt 14):3043-54. PubMed ID: 23687375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of biodegradable polymeric nanoparticles and their controlled drug delivery for tuberculosis.
    Malathi S; Balasubramanian S
    J Biomed Nanotechnol; 2011 Feb; 7(1):150-1. PubMed ID: 21485846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle encapsulated lipopeptide conjugate of antitubercular drug isoniazid: in vitro intracellular activity and in vivo efficacy in a Guinea pig model of tuberculosis.
    Horváti K; Bacsa B; Kiss E; Gyulai G; Fodor K; Balka G; Rusvai M; Szabó E; Hudecz F; Bősze S
    Bioconjug Chem; 2014 Dec; 25(12):2260-8. PubMed ID: 25394206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalization of PLGA Nanoparticles with 1,3-β-glucan Enhances the Intracellular Pharmacokinetics of Rifampicin in Macrophages.
    Tukulula M; Gouveia L; Paixao P; Hayeshi R; Naicker B; Dube A
    Pharm Res; 2018 Mar; 35(6):111. PubMed ID: 29600438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid.
    Booysen LL; Kalombo L; Brooks E; Hansen R; Gilliland J; Gruppo V; Lungenhofer P; Semete-Makokotlela B; Swai HS; Kotze AF; Lenaerts A; du Plessis LH
    Int J Pharm; 2013 Feb; 444(1-2):10-7. PubMed ID: 23357255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity effects of AgZnO nanoparticles and rifampicin on Mycobacterium tuberculosis into the macrophage.
    Jafari A; Jafari Nodooshan S; Safarkar R; Movahedzadeh F; Mosavari N; Novin Kashani A; Dehghanpour M; Kamalzadeh M; Rasouli Koohi S; Fathizadeh S; Majidpour A
    J Basic Microbiol; 2018 Jan; 58(1):41-51. PubMed ID: 29105782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis.
    Hirota K; Hasegawa T; Nakajima T; Inagawa H; Kohchi C; Soma G; Makino K; Terada H
    J Control Release; 2010 Mar; 142(3):339-46. PubMed ID: 19951729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2004 Jul; 54(1):266-8. PubMed ID: 15128731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections.
    Amaral L; Viveiros M
    Int J Antimicrob Agents; 2012 May; 39(5):376-80. PubMed ID: 22445204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matryoshka-type gastro-resistant microparticles for the oral treatment of Mycobacterium tuberculosis.
    Andreu V; Larrea A; Rodriguez-Fernandez P; Alfaro S; Gracia B; Lucía A; Usón L; Gomez AC; Mendoza G; Lacoma A; Dominguez J; Prat C; Sebastian V; Ainsa JA; Arruebo M
    Nanomedicine (Lond); 2019 Mar; 14(6):707-726. PubMed ID: 30734643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why and how thioridazine in combination with antibiotics to which the infective strain is resistant will cure totally drug-resistant tuberculosis.
    Amaral L; Molnar J
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):869-73. PubMed ID: 23030326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.